Cover [Abstract] Document Information [Table] Document Information [Line Items] Document Type Document Period End Date Document Annual Report Entity Registrant Name Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Title of 12(g) Security Title of 12(g) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Icfr Auditor Attestation Flag Icfr Auditor Attestation Flag Entity Public Float Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Consolidated Balance Sheets Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents Unrestricted cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable (less allowance for doubtful accounts of $370 and $162 as of December 31, 2020 and December 31, 2019, respectively; including $172 and $186 from related parties as of December 31, 2020 and December 31, 2019, respectively) Accounts receivable Inventory, Net Inventory Total Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Restricted Cash, Noncurrent Restricted cash Restricted cash Property, Plant and Equipment, Net Property and equipment, net Total Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Goodwill Balance as of end of period Balance as of beginning of period Goodwill Operating Lease, Right-of-Use Asset Right-of-use assets Other Assets, Noncurrent Other non-current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable (including $14 and $36 to related parties as of December 31, 2020 and December 31, 2019, respectively) Accrued Employee Benefits, Current Accrued compensation and benefits Other Accrued Liabilities, Current Other accrued expenses (including $1,377 and $0 to related parties as of December 31, 2020 and December 31, 2019, respectively) Total accrued expenses Contract with Customer, Liability, Current Deferred revenue (including $90 and $55 with related parties as of December 31, 2020 and December 31, 2019, respectively) Deferred revenue Long-term Debt, Current Maturities Current portion of long term debt Operating Lease, Liability, Current Short term lease liabilities Other Liabilities, Current Other current liabilities Liabilities, Current Total current liabilities Contract with Customer, Liability, Noncurrent Deferred revenue, net of current portion Long-term Debt, Excluding Current Maturities Long term debt, net of current portion Operating Lease, Liability, Noncurrent Long term lease liabilities Other Liabilities, Noncurrent Other non-current liabilities Total non-current liabilities Liabilities Total liabilities Commitments and Contingencies. Commitments and contingencies (Note 9) Commitment to sponsor agreement Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock, $0.001 par value: Authorized-120,000,000 shares as of December 31, 2020 and December 31, 2019; issued and outstanding - 31,796,544 and 28,112,201 shares as of December 31, 2020 and December 31, 2019, respectively Common stock, aggregate offering price Additional Paid in Capital, Common Stock Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income (loss) Accumulated other comprehensive income Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Allowance for Doubtful Accounts Receivable, Current Accounts receivable, reserve for doubtful accounts Accounts Receivable, Related Parties, Current Accounts receivable, related parties Accounts Payable, Related Parties, Current Accounts payable, related parties Amount for other accrued liabilities payable to related parties, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Other Accrued Liabilities, Related Parties, Current Other accrued expenses, related parties The carrying amount of consideration received or receivable from related parties as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income. Deferred Revenue, Related Parties, Current Deferred revenue, current, related parties Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, authorized shares Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Condensed Consolidated Statements of Operations Revenue from Contract with Customer, Excluding Assessed Tax Total revenue Revenue Cost of Revenue [Abstract] Costs of goods sold: Cost of Revenue Cost of revenue Total costs of goods sold, services, and licenses Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development (including related party activity of $268, $0, and $0 for the years ended December 31, 2020, 2019, and 2018, respectively) Research and development Selling, General and Administrative Expense Selling, general, and administrative (including related party activity of $36, $0, and $0 for the years ended December 31, 2020, 2019, and 2018) Selling, general and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Interest Income (Expense), Net Interest income (expense), net Other Nonoperating Income (Expense) Other expense, net Other income (expense), net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income (loss) before income taxes Loss before income taxes Income Tax Expense (Benefit) Income tax benefit (provision) Income tax benefit (provision) Total income tax benefit (provision) Net Income (Loss) Attributable to Parent Net income Net loss Net loss Income (Loss) from Continuing Operations, Per Basic and Diluted Share Net loss per share, basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted-average common shares outstanding, basic and diluted Revenue from Related Parties Related party revenue Related Parties Amount in Cost of Sales Cost of product revenue, related party activity Amount included in research and development related to transactions with related parties incurred and recorded in the statement of operations for the period. Related party activity research and development expenses Related party activity in selling, general and administrative expenses Condensed Consolidated Statements of Comprehensive Income (Loss) Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Cumulative translation adjustment Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income (loss) Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Amortization and Accretion, Net Depreciation and amortization expense Inventory Valuation Adjustment Amortization Inventory Valuation Adjustment Amortization Inventory step-up amortization Amount of amortization expense attributable to right-of-use asset. Right-of-Use Asset, Amortization Reduction in the carrying amounts of right-of-use assets Share-based Compensation Stock-based compensation expense Paid-in-Kind Interest Non-cash interest expense Gain (Loss) on Disposition of Property Plant Equipment Loss (gain) on disposal of fixed assets Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Inventories Inventory Increase (Decrease) in Other Noncurrent Assets Other non-current assets Increase (Decrease) in Accounts Payable, Trade Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued compensation and benefits, other accrued expenses and other current liabilities The increase (decrease) in payables for costs incurred to acquire contracts. Increase (Decrease) In Payables For Contract Acquisition Costs Contract acquisition costs The increase (decrease) during the reporting period in the aggregate amount of lease liabilities. Increase Decrease In Operating Lease Liabilities Operating lease liabilities Increase (Decrease) in Other Noncurrent Liabilities Other non-current liabilities Increase (Decrease) in Deferred Revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Investing activities Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment Payments to Acquire Businesses, Net of Cash Acquired Acquisitions, net of cash acquired Purchase price, net The cash inflow from grants for asset purchase. Proceeds From Grant For Asset Purchase Proceeds from RADx grant on assets purchased Payments to Acquire Investments Purchase of Investments Proceeds from Sale of Property, Plant, and Equipment Proceeds from sale of assets Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Financing activities Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from sale of common stock, net of issuance costs Proceeds from Stock Options Exercised Proceeds from stock options exercised Proceeds from Issuance of Common Stock Proceeds from sale of common stock, net of issuance costs Sale of common stock in at-the-market offering, net Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Proceeds from ESPP purchase Repayments of Notes Payable Payments on notes payable Net Cash Provided by (Used in) Financing Activities Net cash provided by (used in) financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase (decrease) in cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Effect of foreign currency exchange rate on cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, restricted cash, and cash equivalents at end of period Cash, restricted cash, and cash equivalents at beginning of period Total cash, cash equivalents, and restricted cash Supplemental Disclosures of Cash Flow Information Supplemental cash flow information Interest Paid, Net Cash paid for interest Capital Expenditures Incurred but Not yet Paid Purchases of property and equipment included in accounts payable Capital Expenditures Incurred Included in Noncurrent Liabilities Capital Expenditures Incurred Included in Noncurrent Liabilities Purchases of property and equipment included in other non-current liabilities The level of ownership or equity interest acquired in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Noncash or Part Noncash Acquisition, Interest Acquired 191,152 shares of common stock issued in connection with the acquisition of UmanDiagnostics AB The fair value amount of common warrants. Fair Value Of Common Warrants Fair value of common stock warrants exercised and reclassified as shares of common stock Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract] Reconciliation of cash, cash equivalents, and restricted cash: Business Combination Consideration Transferred Common Stock Shares Business Combination Consideration Transferred Common Stock Shares Common stock shares consideration Condensed Consolidated Statements of Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Shares, Outstanding Ending Balance (in shares) Beginning balance (in shares) Cumulative Effect of New Accounting Principle in Period of Adoption Cumulative-effect adjustment for the adoption of ASC 606 Value of stock issued as a result of the exercise of warrants. Stock Issued During Period, Value, Warrants Exercised Exercise of common stock warrants Shares of stock issued as a result of the exercise of warrants. Warrants, Exercises in Period Exercise of common stock warrants (in shares) Amount of stock options and vesting restricted stock options exercised. Stock Issued During Period, Value, Stock Options and Vesting Restricted Stock Exercised Exercise of common stock options and vesting restricted stock Number of stock options and vesting restricted stock exercised during the period. Stock Issued During Period, Shares, Stock Options and Vesting Restricted Stock Exercised Exercise of common stock options and vesting restricted stock (in shares) Stock Issued During Period, Value, New Issues Sale of common stock Stock Issued During Period, Shares, New Issues Sale of common stock (in shares) Stock Issued During Period, Shares, New Issues Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Common stock issuance offering costs Stock Issued During Period, Value, Acquisitions Issuance of shares for the acquisition of UmanDiagnostics AB Stock Issued During Period, Shares, Acquisitions Issuance of shares for the acquisition of UmanDiagnostics AB (in shares) Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation expense Stock Issued During Period, Value, Employee Stock Purchase Plan Employee stock purchase plan Stock Issued During Period, Shares, Employee Stock Purchase Plans Employee stock purchase plan (in shares) Organization and operations Nature of Operations [Text Block] Organization and operations Significant accounting policies Significant Accounting Policies [Text Block] Significant accounting policies Inventory Inventory Disclosure [Text Block] Inventory Property and equipment Property, Plant and Equipment Disclosure [Text Block] Property and equipment Other accrued expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Other accrued expenses Income taxes Income Tax Disclosure [Text Block] Income taxes Common Stock, warrants, stock-based compensation, stock options, restricted stock and restricted stock units Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Common Stock, warrants, stock-based compensation, stock options, restricted stock and restricted stock units Leases Lessee, Operating Leases [Text Block] Leases Commitments and contingencies Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Commitments and contingencies Collaboration and license arrangements Commitments Disclosure [Text Block] Commitments and contingencies Notes payable